STRIVE Post-Market Registry Study
NCT: NCT04302272 · RECRUITING
Brief Summary
This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
Frequently Asked Questions
What is STRIVE Post-Market Registry Study?
STRIVE Post-Market Registry Study is a clinical trial registered under NCT04302272. Current status: RECRUITING.
What is the status of NCT04302272?
The current status of NCT04302272 (STRIVE Post-Market Registry Study) is: RECRUITING.
When did STRIVE Post-Market Registry Study start?
STRIVE Post-Market Registry Study started on 2021-10-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.